Table 4.
A path | P value | B path | P value | C path | P value | C′ path | P value | Sobel z-score | P value | % Mediated | R2 | Partial R2for MVPA | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Metabolic risk factor (n=2155), 6–19 years olda | |||||||||||||
Systolic blood pressure (mmHg) | −0.016* | 0.001 | 0.027 | 0.185 | −0.019* | 0.013 | −0.016* | 0.025 | −1.268 | 0.205 | 5.4 | 0.198 | 0.010 |
Diastolic blood pressure (mmHg) | −0.016* | 0.001 | 0.049 | 0.052 | −0.005 | 0.490 | −0.002 | 0.735 | −1.756 | 0.079 | 48.9 | 0.100 | 8.6×10–5 |
C-reactive protein (mg/dL) | −0.016* | 0.001 | 0.005* | 5.5×10–6 | −2.7×10–4 | 0.184 | −1.3×10–4 | 0.499 | −2.986* | 0.003 | 56.9 | 0.058 | 1.2×10–4 |
Total cholesterol (mmol/L) | −0.016* | 0.001 | 0.003 | 0.242 | 0.001 | 0.120 | 0.001 | 0.093 | −1.131 | 0.258 | 8.5 | 0.024 | 0.003 |
High-density lipoprotein cholesterol (mmol/L) | −0.016* | 0.001 | −0.004* | 7.4×10–7 | 0.001* | 0.001 | 4.3×10–4* | 0.005 | 3.086* | 0.002 | 23.1 | 0.178 | 0.004 |
Glycohemoglobin (%)b | −0.009 | 0.127 | 0.002* | 0.024 | 2.7×10–4 | 0.101 | 3.0×10–4 | 0.077 | −1.312 | 0.190 | 9.8 | 0.044 | 0.001 |
Metabolic risk factor (n=1,860), fasting 12- to 19-year-old subsamplea | |||||||||||||
Fasting triglycerides (mmol/L) | 0.002 | 0.879 | 0.004* | 0.023 | 4.7×10–4 | 0.471 | 4.7×10–4 | 0.461 | 0.154 | 0.878 | 2.1 | 0.127 | 0.001 |
Fasting low-density lipoprotein cholesterol (mmol/L) | 0.002 | 0.879 | 0.004 | 0.178 | 0.001 | 0.123 | 0.001 | 0.123 | 0.153 | 0.878 | 0.8 | 0.079 | 0.006 |
Plasma glucose (mmol/L) | 0.002 | 0.879 | −6.5×10−5 | 0.982 | 9.8×10–5 | 0.870 | 9.0×10–5 | 0.882 | −0.023 | 0.982 | 0.2 | 0.067 | 2.5×10–5 |
Fasting insulin (pmol/L) | 0.002 | 0.879 | 0.070* | 7.4×10–8 | −0.027 | 0.388 | −0.002 | 0.285 | 0.154 | 0.878 | 8.5 | 0.439 | 0.002 |
Data presented are standardized beta coefficients and P-values, unless otherwise indicated. Significant results are indicated by an asterisk (*). The “A path” is moderate-to-vigorous physical activity (MVPA; min/day) and relationship to waist circumference while controlling for body mass index (BMI) z-score, age, gender, race/ethnicity, income, total energy intake, total alcohol intake, and smoking status. The “B path” is waist circumference and relationship to metabolic risk factors, controlling for BMI z-score, age, gender, race/ethnicity, income, total energy intake, total alcohol intake, and smoking status. The “C path” is MVPA and relationship to metabolic risk factors, controlling for BMI z-score, age, gender, race/ethnicity, income, total energy intake, total alcohol intake, and smoking status. The “C’ path” is identical to the C path but has the addition of waist circumference as a covariate.
Glycohemoglobin was measured on 12- to 19-year-old participants only.